Biotech Outsourcing

“Drug makers in the United States and Europe are increasingly moving clinical trials and research work to India, which helped Indian firms earn $54 million in revenue in the last fiscal year, a trade body said Wednesday.

“India is being taken seriously as a biotech outsourcing destination,” said Kiran Mazumdar-Shaw, who heads the Association of Biotech Led Enterprises, a grouping of India’s biotechnology firms.”